Ethmozine® (moricizine HCl): A promising drug for “automatic” atrial ectopic tachycardia
- 16 October 1987
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 60 (11) , 83-86
- https://doi.org/10.1016/0002-9149(87)90727-2
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Chronic Supraventricular TachycardiaPublished by American Medical Association (AMA) ,1985
- Effect of moricizine hydrochloride in reducing chronic high-frequency ventricular arrhythmia: Results of a prospective, controlled trialThe American Journal of Cardiology, 1984
- Ethmozine suppression of single and repetitive ventricular premature depolarizations during therapy: Documentation of efficacy and long-term safetyAmerican Heart Journal, 1983
- Fast and slow idioventricular rhythms in the canine heart: A study of their mechanism using antiarrhythmic drugs and electrophysiologic testingThe American Journal of Cardiology, 1982
- Ethmozin, a new antiarrhythmic drug for suppressing ventricular premature complexes.Circulation, 1980
- Ethmozin: A new antiarrhythmic agent developed in the USSR. Efficacy and toleranceAmerican Heart Journal, 1979
- Electrophysiologic and pharmacologic characteristics of automatic ectopic atrial tachycardia.Circulation, 1977
- Electrophysiologic Studies in Patients with Persistent Atrial TachycardiaCirculation, 1974
- The electrophysiologic demonstration of atrial ectopic tachycardia in manAmerican Heart Journal, 1973